DBCCF logo

Decibel Cannabis Company Inc. (DBCCF) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

DBCCF steht fuer Decibel Cannabis Company Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
45/100 KI-Bewertung

Decibel Cannabis Company Inc. (DBCCF) Gesundheitswesen & Pipeline-Uebersicht

CEOBenjamin Sze
Mitarbeiter171
HauptsitzCalgary, CA
IPO-Jahr2019

Decibel Cannabis Company Inc. is a Canadian cannabis company focused on cultivation, processing, and retail sales, offering diverse products under various brands like Qwest and General Admission. With a market capitalization of $0.05 billion and a P/E ratio of 8.46, Decibel operates within Canada's evolving cannabis market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Decibel Cannabis Company Inc. presents a notable research candidate within the Canadian cannabis market, driven by its vertically integrated operations and diverse product portfolio. With a market capitalization of $0.05 billion and a P/E ratio of 8.46, the company demonstrates potential for growth and profitability. Key value drivers include the expansion of its premium brands, such as Qwest and Qwest Reserve, and the increasing demand for cannabis derivative products like vape cartridges and edibles. Growth catalysts include ongoing regulatory developments in Canada, which could further liberalize the cannabis market and increase consumer access. However, potential risks include intense competition from other cannabis producers, fluctuations in cannabis prices, and regulatory uncertainties. Monitoring the company's ability to maintain its gross margin of 36.5% and effectively manage its operating expenses will be crucial for assessing its long-term financial performance.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.05 billion indicates the company's current valuation in the market.
  • P/E ratio of 8.46 suggests the stock may be undervalued compared to its earnings.
  • Gross margin of 36.5% reflects the company's efficiency in converting revenue into profit after accounting for the cost of goods sold.
  • Profit margin of 7.5% indicates the percentage of revenue that remains after all expenses, including cost of goods sold, operating expenses, and taxes, are deducted.
  • Beta of 0.91 suggests the stock is slightly less volatile than the overall market.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Strong brand portfolio (Qwest, General Admission).
  • Vertically integrated operations.
  • High-quality cannabis products.
  • Established presence in the Canadian market.

Schwaechen

  • Limited geographic diversification.
  • Relatively small market capitalization.
  • Dependence on the Canadian cannabis market.
  • Exposure to regulatory changes and uncertainties.

Katalysatoren

  • Upcoming: Potential regulatory changes in Canada that could further liberalize the cannabis market.
  • Ongoing: Expansion of the company's retail footprint through new store openings.
  • Ongoing: Development and launch of new cannabis derivative products.
  • Ongoing: Strategic partnerships and acquisitions to expand market reach.
  • Ongoing: Increasing consumer demand for premium cannabis products.

Risiken

  • Ongoing: Intense competition from other cannabis producers in Canada.
  • Potential: Fluctuations in cannabis prices impacting profitability.
  • Potential: Regulatory changes and uncertainties affecting the cannabis industry.
  • Potential: Negative perceptions of cannabis impacting consumer demand.
  • Ongoing: Limited liquidity and trading volume on the OTC market.

Wachstumschancen

  • Expansion of Derivative Product Offerings: Decibel can capitalize on the growing demand for cannabis derivative products, such as vape cartridges, edibles, and extracts. The market for these products is projected to reach $2.5 billion in Canada by 2028. By investing in research and development, Decibel can introduce innovative and high-quality derivative products that appeal to a wider range of consumers. This includes developing new flavors, formulations, and delivery methods to differentiate its offerings from competitors. The timeline for this growth opportunity is immediate, with ongoing product development and launches expected over the next few years.
  • Strategic Partnerships and Acquisitions: Decibel can pursue strategic partnerships and acquisitions to expand its market reach and product portfolio. Collaborating with other cannabis companies, retailers, or technology providers can provide access to new markets, distribution channels, and innovative technologies. Acquisitions can also enable Decibel to acquire complementary brands, production facilities, or intellectual property. The timeline for this growth opportunity is medium-term, with potential partnerships and acquisitions occurring over the next 3-5 years.
  • International Expansion: As cannabis regulations evolve globally, Decibel can explore opportunities to expand its operations into international markets. Countries like Germany, Australia, and the United States are showing increasing interest in legalizing or decriminalizing cannabis. By establishing a presence in these markets, Decibel can tap into new sources of revenue and diversify its geographic footprint. The timeline for this growth opportunity is long-term, with potential international expansion occurring over the next 5-10 years.
  • Focus on Premium Brands: Decibel's Qwest and Qwest Reserve brands are positioned as premium cannabis products, targeting discerning consumers who value quality and craftsmanship. By investing in marketing and branding efforts, Decibel can further enhance the reputation of these brands and increase their market share. This includes highlighting the unique characteristics of the products, such as the cultivation methods, terpene profiles, and cannabinoid content. The timeline for this growth opportunity is ongoing, with continuous efforts to strengthen the brand equity and consumer loyalty.
  • Retail Expansion: Decibel can expand its retail footprint by opening new cannabis stores in strategic locations across Canada. This will allow the company to directly interact with consumers, showcase its products, and provide a personalized shopping experience. The retail expansion can be achieved through organic growth, acquisitions, or partnerships with existing retailers. The timeline for this growth opportunity is medium-term, with potential new store openings occurring over the next 3-5 years. The Canadian cannabis retail market is projected to reach $6 billion by 2027.

Chancen

  • Expansion into international markets.
  • Development of new cannabis derivative products.
  • Strategic partnerships and acquisitions.
  • Increased consumer demand for premium cannabis products.

Risiken

  • Intense competition from other cannabis producers.
  • Fluctuations in cannabis prices.
  • Regulatory changes and uncertainties.
  • Negative perceptions of cannabis.

Wettbewerbsvorteile

  • Premium brand recognition (Qwest, Qwest Reserve).
  • Vertically integrated operations.
  • Proprietary cultivation and processing techniques.
  • Established distribution network in Canada.

Ueber DBCCF

Decibel Cannabis Company Inc., headquartered in Calgary, Canada, is a vertically integrated cannabis company involved in the cultivation, processing, production, and retail sale of cannabis products. The company offers a diverse portfolio of cannabis flower, pre-rolls, and biomass to licensed producers across Canada. Furthermore, Decibel engages in the extraction, processing, and manufacturing of cannabis derivative products, including vape cartridges, cannabis-infused edibles, and cannabis extracts. The company's brand portfolio includes Qwest, Qwest Reserve, Blendcraft by Qwest, and General Admission, each targeting different consumer segments within the cannabis market. Decibel's operations span from upstream cultivation to downstream retail, allowing for greater control over product quality and supply chain efficiencies. The company aims to establish itself as a premium cannabis provider within the Canadian market, focusing on product innovation and consumer experience. Founded with a vision to deliver high-quality cannabis products, Decibel has strategically expanded its production capabilities and brand presence to capitalize on the growing demand for recreational and medicinal cannabis in Canada.

Was das Unternehmen tut

  • Cultivates cannabis flower and biomass.
  • Processes cannabis to create various derivative products.
  • Manufactures cannabis vape cartridges.
  • Produces cannabis-infused products like edibles.
  • Extracts cannabis oils and concentrates.
  • Retails cannabis products through its own stores and partnerships.
  • Offers cannabis pre-rolls under various brands.

Geschaeftsmodell

  • Cultivation and production of cannabis products.
  • Wholesale distribution to licensed producers.
  • Retail sales through company-owned stores.
  • Brand licensing and partnerships.

Branchenkontext

Decibel Cannabis Company Inc. operates within the rapidly evolving Canadian cannabis industry, which has experienced significant growth since legalization. The market is characterized by increasing consumer demand for both recreational and medicinal cannabis products. Decibel competes with other licensed producers, including DXBRF, ELIXF, ETST, FLOOF, and INIS, as well as larger industry players. The company's focus on premium brands and derivative products positions it to capture a share of the higher-margin segments of the market. The industry is subject to ongoing regulatory changes and evolving consumer preferences, requiring companies to adapt and innovate to maintain a competitive edge.

Wichtige Kunden

  • Licensed cannabis producers in Canada.
  • Recreational cannabis consumers.
  • Medical cannabis patients.
  • Retail partners and distributors.
KI-Zuversicht: 71% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Decibel Cannabis Company Inc. (DBCCF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DBCCF.

Kursziele

Wall-Street-Kurszielanalyse fuer DBCCF.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von DBCCF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Benjamin Sze

CEO

Benjamin Sze serves as the CEO of Decibel Cannabis Company Inc. His background includes extensive experience in managing and scaling businesses within regulated industries. Sze has a proven track record of driving growth and profitability through strategic planning, operational excellence, and effective team leadership. He holds a strong understanding of the Canadian cannabis market and the evolving regulatory landscape. His expertise spans across various aspects of the cannabis industry, including cultivation, processing, and retail operations.

Erfolgsbilanz: Under Benjamin Sze's leadership, Decibel Cannabis Company Inc. has focused on expanding its premium brand portfolio and optimizing its production capabilities. Key achievements include the successful launch of new cannabis derivative products and the expansion of the company's retail footprint. Sze has also played a crucial role in navigating the complex regulatory environment and securing strategic partnerships to drive growth.

DBCCF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Decibel Cannabis Company Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for DBCCF on the OTC market is likely limited, given its OTC Other tier status. This may result in wider bid-ask spreads and difficulty in executing large trades without significantly impacting the stock price. Investors should be aware of the potential for price volatility and consider using limit orders to manage their risk.
OTC-Risikofaktoren:
  • Limited liquidity and trading volume.
  • Lack of regulatory oversight and disclosure requirements.
  • Potential for price manipulation and fraud.
  • Higher risk of financial distress or bankruptcy.
  • Limited access to capital and funding.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and licensing status.
  • Review the company's financial statements and disclosures.
  • Assess the company's management team and track record.
  • Evaluate the company's business model and competitive landscape.
  • Understand the regulatory environment and potential risks.
  • Check for any legal or regulatory issues.
  • Monitor news and developments related to the company.
Legitimitaetssignale:
  • Established operations in the Canadian cannabis market.
  • Positive customer reviews and brand reputation.
  • Compliance with Canadian cannabis regulations.
  • Audited financial statements (if available).
  • Experienced management team.

DBCCF Healthcare Aktien-FAQ

What are the key factors to evaluate for DBCCF?

Decibel Cannabis Company Inc. (DBCCF) currently holds an AI score of 45/100, indicating low score. Key strength: Strong brand portfolio (Qwest, General Admission).. Primary risk to monitor: Ongoing: Intense competition from other cannabis producers in Canada.. This is not financial advice.

How frequently does DBCCF data refresh on this page?

DBCCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven DBCCF's recent stock price performance?

Recent price movement in Decibel Cannabis Company Inc. (DBCCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand portfolio (Qwest, General Admission).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider DBCCF overvalued or undervalued right now?

Determining whether Decibel Cannabis Company Inc. (DBCCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying DBCCF?

Before investing in Decibel Cannabis Company Inc. (DBCCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding DBCCF to a portfolio?

Potential reasons to consider Decibel Cannabis Company Inc. (DBCCF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Strong brand portfolio (Qwest, General Admission).. Additionally: Vertically integrated operations.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of DBCCF?

Yes, most major brokerages offer fractional shares of Decibel Cannabis Company Inc. (DBCCF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track DBCCF's earnings and financial reports?

Decibel Cannabis Company Inc. (DBCCF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DBCCF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data and may be subject to change.
  • OTC market data may be limited or less reliable than exchange-listed data.
Datenquellen

Popular Stocks